205 related articles for article (PubMed ID: 12508143)
1. Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals.
Barron MA; Blyveis N; Palmer BE; MaWhinney S; Wilson CC
J Infect Dis; 2003 Jan; 187(1):26-37. PubMed ID: 12508143
[TBL] [Abstract][Full Text] [Related]
2. Defects in blood dendritic cell subsets in HIV-1 subtype c infected Indians.
Mojumdar K; Vajpayee M; Chauhan NK; Mendiratta S; Wig N
Indian J Med Res; 2010 Sep; 132():318-27. PubMed ID: 20847379
[TBL] [Abstract][Full Text] [Related]
3. Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children.
Azzoni L; Rutstein RM; Chehimi J; Farabaugh MA; Nowmos A; Montaner LJ
J Infect Dis; 2005 May; 191(9):1451-9. PubMed ID: 15809903
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses.
Athanassopoulos P; Vaessen LM; Maat AP; Balk AH; Weimar W; Bogers AJ
Eur J Cardiothorac Surg; 2004 Apr; 25(4):619-26. PubMed ID: 15037281
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.
Reynes J; Portales P; Segondy M; Baillat V; André P; Réant B; Avinens O; Couderc G; Benkirane M; Clot J; Eliaou JF; Corbeau P
J Infect Dis; 2000 Mar; 181(3):927-32. PubMed ID: 10720514
[TBL] [Abstract][Full Text] [Related]
7. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
[TBL] [Abstract][Full Text] [Related]
8. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
9. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.
Deeks SG; Martin JN; Sinclair E; Harris J; Neilands TB; Maecker HT; Hagos E; Wrin T; Petropoulos CJ; Bredt B; McCune JM
J Infect Dis; 2004 Jan; 189(2):312-21. PubMed ID: 14722897
[TBL] [Abstract][Full Text] [Related]
10. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
Dillon SM; Friedlander LJ; Rogers LM; Meditz AL; Folkvord JM; Connick E; McCarter MD; Wilson CC
J Virol; 2011 Jan; 85(1):397-409. PubMed ID: 20962079
[TBL] [Abstract][Full Text] [Related]
11. B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection.
Wang X; Zhang Z; Zhang S; Fu J; Yao J; Jiao Y; Wu H; Wang FS
Eur J Immunol; 2008 Nov; 38(11):3226-36. PubMed ID: 18924219
[TBL] [Abstract][Full Text] [Related]
12. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
13. HCV viremia drives an increment of CD86 expression by myeloid dendritic cells.
Malta FM; Bruno FR; Carvalho KI; Nastri AC; Kalil J; Carrilho FJ; Kallas EG; Pinho JR
J Med Virol; 2013 Nov; 85(11):1919-24. PubMed ID: 23926073
[TBL] [Abstract][Full Text] [Related]
14. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection.
Almeida M; Cordero M; Almeida J; Orfao A
AIDS; 2005 Feb; 19(3):261-71. PubMed ID: 15718836
[TBL] [Abstract][Full Text] [Related]
15. Early plasmacytoid dendritic cell changes predict plasma HIV load rebound during primary infection.
Pacanowski J; Develioglu L; Kamga I; Sinet M; Desvarieux M; Girard PM; Hosmalin A
J Infect Dis; 2004 Nov; 190(10):1889-92. PubMed ID: 15499547
[TBL] [Abstract][Full Text] [Related]
16. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
Killian MS; Fujimura SH; Hecht FM; Levy JA
AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
[TBL] [Abstract][Full Text] [Related]
17. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
18. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
[TBL] [Abstract][Full Text] [Related]
19. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
20. The value of preserving HIV-specific immune responses.
Kaufmann DE; Rosenberg ES
J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
